Serum Institute rejects charges levelled by vaccine trial participant, threatens to seek damages

By: |
November 29, 2020 8:18 PM

Vaccine major Serum Institute of India on Sunday rejected charges that a COVID-19 vaccine candidate has serious side effects, and threatened to seek heavy damages for "malicious" allegations.

Coronavirus vaccine, Coronavirus vaccine news, Coronavirus vaccine update, Coronavirus vaccine news, Covid 19 vaccine, covid 19 vaccine update, oxford vaccine results, oxford vaccine efficacy, astrazeneca vaccine, astrazeneca news, astrazeneca coronavirus vaccinePune-based Serum Institute of India (SII) has collaborated with Oxford University and pharmaceutial company Astra Zeneca for making the COVID-19 vaccine, 'Covidshield', and is conducting trials in India.

Vaccine major Serum Institute of India on Sunday rejected charges that a COVID-19 vaccine candidate has serious side effects, and threatened to seek heavy damages for “malicious” allegations. A 40-year-old man who took part in the ‘Covidshield’ vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and has sought Rs 5 crore compensation in a legal notice to Serum Institute and others, besides seeking a halt to the trial.

“The allegations in the notice are malicious and misconceived. While the Serum Institute of India is sympathetic with the volunteer’s medical condition, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer,” Serum Institute of India said in a statement. The volunteer is falsely laying the blame for his medical problems on the COVID vaccine trial, it added.

“It is evident that the intention behind the spreading of such malicious information is an oblique pecuniary motive. The Serum Institute of India, will seek damages in excess of 100 crore for the same and will defend such malicious claims,” Serum Institute said. Pune-based Serum Institute of India (SII) has collaborated with Oxford University and pharmaceutial company Astra Zeneca for making the COVID-19 vaccine, ‘Covidshield’, and is conducting trials in India.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Andhra Pradesh: Less than 50 per cent beneficiaries show up for COVID-19 vaccination
2Good news for vegetarians! CSIR survey says those with such dietary preference may have lesser risk of contracting coronavirus
3On Day 2, six states get coronavirus vaccine sessions; Centre says ‘adverse effects’ very minor